Mallinckrodt Pharmaceuticals soared in premarket trading Tuesday after the company released first-quarter earnings that beat Wall Street's expectations and raised its profit outlook for the year.
Mallinckrodt Pharmaceuticals soared in premarket trading Tuesday after the company released first-quarter earnings that beat Wall Street's expectations and raised its profit outlook for the year.